Immunocore Holdings (IMCR) Tax Provisions (2021 - 2026)
Immunocore Holdings (IMCR) posted quarterly Tax Provisions of $301000.0 for Q1 2026, down 72.64% year-on-year from $1.1 million in Q1 2025, and down 97.89% on a QoQ basis from $14.3 million in Q4 2025.
Immunocore Holdings (IMCR) Tax Provisions (2021 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Tax Provisions for 6 consecutive years, with $301000.0 the latest figure, recorded in Q1 2026.
- Quarterly Tax Provisions fell 72.64% year-over-year to $301000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 1533.94% YoY) and the FY2025 annual result came in at $16.4 million, up 987.24% from the prior year.
- Tax Provisions fell to $301000.0 in Q1 2026 per IMCR's latest filing, from $14.3 million in the prior quarter.
- Over the last five years, Tax Provisions for IMCR reached as high as $14.3 million in Q4 2025 and fell as low as -$5.9 million in Q4 2023.
- A 5-year average of $481704.1 and a median of $300500.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2024 — Tax Provisions plunged 1410.29% — and 2025, when it jumped 1458.67%.
- Year by year, Tax Provisions stood at $2.5 million in 2022, then slumped by 336.71% to -$5.9 million in 2023, then surged by 82.24% to -$1.0 million in 2024, then soared by 1458.67% to $14.3 million in 2025, then slumped by 97.89% to $301000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $301000.0, $14.3 million, and $500000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn | 301,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | 14.27 Mn |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 606,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -1.05 Mn |
| Sep 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | -5.91 Mn |
| Sep 30, 2023 | -175,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | -1.47 Mn |
| Jun 30, 2022 | -2.71 Mn |
| Dec 31, 2021 | 288,474.27 |
| Sep 30, 2021 | -2.93 Mn |